Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.03
-0.27 (-2.62%)
At close: Nov 16, 2026, 4:00 PM EST
10.18
+0.15 (1.50%)
After-hours: Nov 16, 2026, 7:30 PM EST

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $40.01M in the quarter ending September 30, 2026, with 180.53% growth. This brings the company's total for the last twelve months to $40.76M, down -83.48% year-over-year. In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth. That makes Keros Therapeutics the 29,432nd largest company in the world by revenue and 3,912th in the United States.

Revenue (ttm)
$40.76M
Revenue Growth
-83.48%
P/S Ratio
4.85
Revenue / Employee
$468,517
Employees
87
Market Cap
196.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020---
Dec 31, 201910.00M--
Dec 31, 201810.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.